Articles

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.

Anatomic Pathology Service, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain;
Translational Hematopathology Lab, IDIVAL, (CIBERONC), Santander, Spain;
Cytogenetics Unit, Department of Hematology, HUMV, Santander, Spain;
Hematopathology Department, MD Anderson Cancer Center, Houston, TX, USA;
Translational Hematopathology Lab, IDIVAL, CIBERONC, Santander, Spain;
CNAG-CRG, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona, Spain;
CNAG-CRG, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona, Spain;
CNAG-CRG, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona, Spain;
Translational Hematopathology Lab, IDIVAL, CIBERONC, Santander, Spain;
Departments of Pathology and Hematology, San Bortolo Hospital, Vicenza, Italy;
Department of Medicine, Section of Hematology, University of Verona, San Bortolo Hospital, Italy
Hematopathology Department, MD Anderson Cancer Center, Houston, TX, USA;
Anatomic Pathology Service, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain;
Haematologica Early view Apr 9, 2020 https://doi.org/10.3324/haematol.2020.251579